Selwyn AP - Search Results

1

Atherogenic lipids, vascular dysfunction, and clinical signs of ischemic heart disease.

Selwyn AP, Kinlay S, Libby P, Ganz P. Selwyn AP, et al. Circulation. 1997 Jan 7;95(1):5-7. doi: 10.1161/01.cir.95.1.5. Circulation. 1997. PMID: 8994406

2

Effect of intensive lipid lowering, with or without antioxidant vitamins, compared with moderate lipid lowering on myocardial ischemia in patients with stable coronary artery disease: the Vascular Basis for the Treatment of Myocardial Ischemia Study.

Stone PH, Lloyd-Jones DM, Kinlay S, Frei B, Carlson W, Rubenstein J, Andrews TC, Johnstone M, Sopko G, Cole H, Orav J, Selwyn AP, Creager MA; Vascular Basis Study Group. Stone PH, et al. Among authors: selwyn ap. Circulation. 2005 Apr 12;111(14):1747-55. doi: 10.1161/01.CIR.0000160866.90148.76. Epub 2005 Apr 4. Circulation. 2005. PMID: 15809368 Clinical Trial.

3

Lipid lowering improves endothelial functions.

Libby P, Aikawa M, Kinlay S, Selwyn A, Ganz P. Libby P, et al. Int J Cardiol. 2000 Jun 30;74 Suppl 1:S3-S10. doi: 10.1016/s0167-5273(99)00105-9. Int J Cardiol. 2000. PMID: 10856767 Review.

4

Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels.

Treasure CB, Klein JL, Vita JA, Manoukian SV, Renwick GH, Selwyn AP, Ganz P, Alexander RW. Treasure CB, et al. Among authors: selwyn ap. Circulation. 1993 Jan;87(1):86-93. doi: 10.1161/01.cir.87.1.86. Circulation. 1993. PMID: 8419028

5

Role of nitric oxide in the local regulation of pulmonary vascular resistance in humans.

Cooper CJ, Landzberg MJ, Anderson TJ, Charbonneau F, Creager MA, Ganz P, Selwyn AP. Cooper CJ, et al. Among authors: selwyn ap. Circulation. 1996 Jan 15;93(2):266-71. doi: 10.1161/01.cir.93.2.266. Circulation. 1996. PMID: 8548898

6

Early endothelial dysfunction predicts the development of transplant coronary artery disease at 1 year posttransplant.

Davis SF, Yeung AC, Meredith IT, Charbonneau F, Ganz P, Selwyn AP, Anderson TJ. Davis SF, et al. Among authors: selwyn ap. Circulation. 1996 Feb 1;93(3):457-62. doi: 10.1161/01.cir.93.3.457. Circulation. 1996. PMID: 8565162

7

Endothelium-dependent coronary vasomotion relates to the susceptibility of LDL to oxidation in humans.

Anderson TJ, Meredith IT, Charbonneau F, Yeung AC, Frei B, Selwyn AP, Ganz P. Anderson TJ, et al. Among authors: selwyn ap. Circulation. 1996 May 1;93(9):1647-50. doi: 10.1161/01.cir.93.9.1647. Circulation. 1996. PMID: 8653869

8

Effect of cholesterol reduction on myocardial ischemia in patients with coronary disease.

Andrews TC, Raby K, Barry J, Naimi CL, Allred E, Ganz P, Selwyn AP. Andrews TC, et al. Among authors: selwyn ap. Circulation. 1997 Jan 21;95(2):324-8. doi: 10.1161/01.cir.95.2.324. Circulation. 1997. PMID: 9008444 Clinical Trial.

9

Biological mechanisms for the clinical success of lipid-lowering in coronary artery disease and the use of surrogate end-points.

Kinlay S, Selwyn AP, Delagrange D, Creager MA, Libby P, Ganz P. Kinlay S, et al. Among authors: selwyn ap. Curr Opin Lipidol. 1996 Dec;7(6):389-97. doi: 10.1097/00041433-199612000-00009. Curr Opin Lipidol. 1996. PMID: 9117144 Review.

10

Cell dysfunction in atherosclerosis and the ischemic manifestations of coronary artery disease.

Selwyn AP, Kinlay S, Creager M, Libby P, Ganz P. Selwyn AP, et al. Am J Cardiol. 1997 Mar 6;79(5A):17-23. doi: 10.1016/s0002-9149(97)00125-2. Am J Cardiol. 1997. PMID: 9127617 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

231 results

Search Page

Filters